Acquisition of Kbiosystems Limited

RNS Number : 4278Q
Porvair PLC
26 February 2021
 

26 February 2021

 

 

Porvair plc ("Porvair" or "The Group")

 

Acquisition of Kbiosystems Limited

 

Porvair, the specialist filtration, laboratory and environmental technologies group, is pleased to announce the acquisition of Kbiosystems Limited ("Kbiosystems").

Kbiosystems is based in Basildon, UK and specialises in the design and manufacture of laboratory instruments, with particular expertise in automated microplate handling systems.  On 25 February 2021, the Group acquired 100 per cent. of the share capital of Kbiosystems, which reported revenue of £3.8 million in the year ended 31 March 2020.

Kbiosystems will continue to operate from its existing premises and will be integrated into the Group's Laboratory division.

Commenting on the acquisition, Ben Stocks, Chief Executive, said:

"We are delighted that Kbiosystems has joined the Group.  We have known the business for many years and there is a good fit between our laboratory consumables business and Kbiosystems instrument automation expertise.  Together the businesses have a compelling offering for laboratories seeking to automate their sample testing processes."

 

For more information, contact:

 

Porvair plc


Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500



Buchanan Communications

0207 466 5000

Charles Ryland /Stephanie Watson


 

 

Notes to Editors

Porvair is a group of specialist filtration, separation and environmental technologies businesses.  Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems.  It is organised into three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDGGDDLDDDGBU

Companies

Porvair (PRV)
UK 100

Latest directors dealings